BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35255496)

  • 21. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer's disease-like neuropathology.
    Lim SL; Tran DN; Zumkehr J; Chen C; Ghiaar S; Kieu Z; Villanueva E; Gallup V; Rodriguez-Ortiz CJ; Kitazawa M
    Glia; 2018 Dec; 66(12):2700-2718. PubMed ID: 30277607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate FcepsilonRI-dependent mast cell activation and allergic responses.
    Samayawardhena LA; Pallen CJ
    J Immunol; 2010 Nov; 185(10):5993-6002. PubMed ID: 20944008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
    Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
    Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Src kinases and Syk in Fcgamma receptor-mediated phagocytosis and phagosome-lysosome fusion.
    Majeed M; Caveggion E; Lowell CA; Berton G
    J Leukoc Biol; 2001 Nov; 70(5):801-11. PubMed ID: 11698501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.
    Castillo JJ; Hunter ZR; Yang G; Treon SP
    Expert Rev Hematol; 2017 Aug; 10(8):739-744. PubMed ID: 28617062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal/Tirap, suppressing LPS-induced inflammatory responses.
    Mitchell J; Kim SJ; Seelmann A; Veit B; Shepard B; Im E; Rhee SH
    Biochem Pharmacol; 2018 Jan; 147():119-127. PubMed ID: 29175418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.
    Trible RP; Emert-Sedlak L; Smithgall TE
    J Biol Chem; 2006 Sep; 281(37):27029-38. PubMed ID: 16849330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
    Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M
    Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of AMPK through Lyn-Syk-Akt enhances FcεRI signal pathways for allergic response.
    Lin KC; Huang DY; Huang DW; Tzeng SJ; Lin WW
    J Mol Med (Berl); 2016 Feb; 94(2):183-94. PubMed ID: 26373430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.
    Yang G; Zhou Y; Liu X; Xu L; Cao Y; Manning RJ; Patterson CJ; Buhrlage SJ; Gray N; Tai YT; Anderson KC; Hunter ZR; Treon SP
    Blood; 2013 Aug; 122(7):1222-32. PubMed ID: 23836557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.
    Priceputu E; Cool M; Bouchard N; Caceres-Cortes JR; Lowell CA; Hanna Z; Jolicoeur P
    J Virol; 2021 Aug; 95(17):e0047121. PubMed ID: 34106001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Src family kinase Fgr is critical for activation of mast cells and IgE-mediated anaphylaxis in mice.
    Lee JH; Kim JW; Kim DK; Kim HS; Park HJ; Park DK; Kim AR; Kim B; Beaven MA; Park KL; Kim YM; Choi WS
    J Immunol; 2011 Aug; 187(4):1807-15. PubMed ID: 21746961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristic expression of Hck in human B-cell precursors.
    Taguchi T; Kiyokawa N; Sato N; Saito M; Fujimoto J
    Exp Hematol; 2000 Jan; 28(1):55-64. PubMed ID: 10658677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes.
    Li HL; Davis WW; Whiteman EL; Birnbaum MJ; Puré E
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6890-5. PubMed ID: 10359809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.
    Schreiner SJ; Schiavone AP; Smithgall TE
    J Biol Chem; 2002 Nov; 277(47):45680-7. PubMed ID: 12244095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma.
    Bogusz AM; Baxter RH; Currie T; Sinha P; Sohani AR; Kutok JL; Rodig SJ
    Clin Cancer Res; 2012 Nov; 18(22):6122-35. PubMed ID: 22966017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine Kinase SYK Licenses MyD88 Adaptor Protein to Instigate IL-1α-Mediated Inflammatory Disease.
    Gurung P; Fan G; Lukens JR; Vogel P; Tonks NK; Kanneganti TD
    Immunity; 2017 Apr; 46(4):635-648. PubMed ID: 28410990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck.
    Lionberger JM; Wilson MB; Smithgall TE
    J Biol Chem; 2000 Jun; 275(24):18581-5. PubMed ID: 10849448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of syk in an immature B cell line does not require lyn activity.
    Muthukkumar S; Venkataraman C; Woods T; Bondada S
    Mol Immunol; 1997; 34(12-13):865-75. PubMed ID: 9464522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr.
    Warmuth M; Bergmann M; Priess A; Häuslmann K; Emmerich B; Hallek M
    J Biol Chem; 1997 Dec; 272(52):33260-70. PubMed ID: 9407116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.